Novavax, Inc.

Organization

GAITHERSBURG, MD, US

Ticker Symbols

NASDAQ:NVAX

BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Address
20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
Mailing Address
20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
State Location
MD
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for inducing immune responses against Clos...
- Patent number 11,938,179
- Issue date Mar 26, 2024
- Novavax, Inc.
- Jing-Hui Tian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent influenza nanoparticle vaccines
- Patent number 11,896,662
- Issue date Feb 13, 2024
- Novavax, Inc.
- Sarathi Boddapati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Corona virus vaccine formulations
- Patent number 11,896,664
- Issue date Feb 13, 2024
- Novavax, Inc.
- Gale Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Coronavirus vaccine formulations
- Patent number 11,541,112
- Issue date Jan 3, 2023
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 11,446,374
- Issue date Sep 20, 2022
- Novavax, Inc.
- Peter M. Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccine compositions having improved stability and immunogenicity
- Patent number 11,364,294
- Issue date Jun 21, 2022
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent influenza nanoparticle vaccines
- Patent number 11,278,612
- Issue date Mar 22, 2022
- Novavax, Inc.
- Sarathi Boddapati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccine compositions having improved stability and immunogenicity
- Patent number 11,253,585
- Issue date Feb 22, 2022
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coronavirus vaccine formulations
- Patent number 11,253,586
- Issue date Feb 22, 2022
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inducing immune responses against Clos...
- Patent number 11,123,419
- Issue date Sep 21, 2021
- Novavax, Inc.
- Jing-Hui Tian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 11,052,146
- Issue date Jul 6, 2021
- Novavax, Inc.
- Peter M. Pushko
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Coronavirus vaccine formulations
- Patent number 10,953,089
- Issue date Mar 23, 2021
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition comprising iscom particles and live micro-organisms
- Patent number 10,813,994
- Issue date Oct 27, 2020
- Novavax AB
- Bror Morein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV)...
- Patent number 10,751,410
- Issue date Aug 25, 2020
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Influenza vaccine
- Patent number 10,736,958
- Issue date Aug 11, 2020
- Novavax AB
- Albertus D. M. E. Osterhaus
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
ISCOM preparation and use thereof
- Patent number 10,729,764
- Issue date Aug 4, 2020
- Novavax AB
- Bror Morein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus like particles (VLPs)
- Patent number 10,729,760
- Issue date Aug 4, 2020
- Novavax, Inc.
- Gale Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Functional influenza virus-like particles (VLPS)
- Patent number 10,548,968
- Issue date Feb 4, 2020
- Novavax, Inc.
- Gale Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Highly efficient influenza matrix (M1) proteins
- Patent number 10,544,399
- Issue date Jan 28, 2020
- Novavax, Inc.
- Gale Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Influenza vaccine
- Patent number 10,485,863
- Issue date Nov 26, 2019
- Novavax AB
- Albertus D. M. E. Osterhaus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccine compositions having improved stability and immunogenicity
- Patent number 10,426,829
- Issue date Oct 1, 2019
- Novavax, Inc.
- Gale Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Functional influenza virus like particles (VLPs)
- Patent number 10,188,723
- Issue date Jan 29, 2019
- Novavax, Inc.
- Gale Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Rabies glycoprotein virus-like particles (VLPS)
- Patent number 10,086,065
- Issue date Oct 2, 2018
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 10,022,437
- Issue date Jul 17, 2018
- Novavax, Inc.
- Peter Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus-like particles (VLPs)
- Patent number 9,956,280
- Issue date May 1, 2018
- Novavax, Inc.
- Robin A. Robinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly efficient influenza matrix (M1) proteins
- Patent number 9,951,317
- Issue date Apr 24, 2018
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus-like particles (VLPS)
- Patent number 9,937,253
- Issue date Apr 10, 2018
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions comprising iscom particles and live micro-organisms
- Patent number 9,901,634
- Issue date Feb 27, 2018
- Novavax AB
- Bror Morein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 9,731,000
- Issue date Aug 15, 2017
- Novavax, Inc.
- Peter M. Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Rabies glycoprotein virus-like particles (VLPS)
- Patent number 9,724,405
- Issue date Aug 8, 2017
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20240165221
- Publication date May 23, 2024
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DOWNSTREAM PROCESS FOR PURIFICATION OF VIRAL PROTEINS WITH HYDROPHO...
- Publication number 20240076320
- Publication date Mar 7, 2024
- NOVAVAX, INC.
- Timothy Hahn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF
- Publication number 20240024468
- Publication date Jan 25, 2024
- Novavax AB
- Bror Morein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20230330216
- Publication date Oct 19, 2023
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
- Publication number 20230293667
- Publication date Sep 21, 2023
- NOVAVAX, INC.
- Peter M. PUSHKO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20230070886
- Publication date Mar 9, 2023
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY
- Publication number 20220387579
- Publication date Dec 8, 2022
- NOVAVAX, INC.
- Gale SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM
- Publication number 20220354944
- Publication date Nov 10, 2022
- NOVAVAX, INC.
- Nita PATEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20220332765
- Publication date Oct 20, 2022
- NOVAVAX, INC.
- Gale SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF
- Publication number 20220241408
- Publication date Aug 4, 2022
- Novavax AB
- Bror Morein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOS...
- Publication number 20220211834
- Publication date Jul 7, 2022
- NOVAVAX, INC.
- Jing-Hui TIAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20220125914
- Publication date Apr 28, 2022
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTIVALENT INFLUENZA NANOPARTICLE VACCINES
- Publication number 20220080039
- Publication date Mar 17, 2022
- NOVAVAX, INC.
- Sarathi BODDAPATI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20210228708
- Publication date Jul 29, 2021
- NOVAVAX, INC.
- Gale SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20210228709
- Publication date Jul 29, 2021
- NOVAVAX, INC.
- Gale SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE
- Publication number 20210137845
- Publication date May 13, 2021
- NOVAVAX, INC.
- Gale SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF
- Publication number 20200345840
- Publication date Nov 5, 2020
- Novavax AB
- Bror Morein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITION COMPRISING ISCOM PARTICLES AND LIVE MICRO-ORGANISMS
- Publication number 20200323979
- Publication date Oct 15, 2020
- Novavax AB
- Bror Morein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISCOM PREPARATION AND USE THEREOF
- Publication number 20200215189
- Publication date Jul 9, 2020
- Novavax AB
- BROR MOREIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY
- Publication number 20200101151
- Publication date Apr 2, 2020
- NOVAVAX, INC.
- Gale SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOS...
- Publication number 20200085934
- Publication date Mar 19, 2020
- NOVAVAX, INC.
- Jing-Hui TIAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
- Publication number 20200030436
- Publication date Jan 30, 2020
- NOVAVAX, INC.
- Peter M. PUSHKO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INFLUENZA VACCINE
- Publication number 20190388534
- Publication date Dec 26, 2019
- Novavax AB
- Albertus D.M.E. OSTERHAUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)
- Publication number 20190314484
- Publication date Oct 17, 2019
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTIVALENT INFLUENZA NANOPARTICLE VACCINES
- Publication number 20190314487
- Publication date Oct 17, 2019
- NOVAVAX, INC.
- Sarathi BODDAPATI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPS)
- Publication number 20190224307
- Publication date Jul 25, 2019
- NOVAVAX, INC.
- Gale SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
- Publication number 20190134187
- Publication date May 9, 2019
- NOVAVAX, INC.
- Peter M. PUSHKO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY EFFICIENT INFLUENZA MATRIX (M1) PROTEINS
- Publication number 20190062713
- Publication date Feb 28, 2019
- NOVAVAX, INC.
- Gale SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)
- Publication number 20190038738
- Publication date Feb 7, 2019
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF
- Publication number 20180369368
- Publication date Dec 27, 2018
- Novavax AB
- Bror Morein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
98117267 - CHOOSE TO PROTECT
- Serial number 98117267
- Filing date Aug 4, 2023
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97696833 - ORDINARY IS EXTRAORDINARY
- Serial number 97696833
- Filing date Nov 29, 2022
- Novavax, Inc.
- 35 - Advertising
Information Trademark
97681661 - VAXDUET
- Serial number 97681661
- Filing date Nov 17, 2022
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97681662 - VAXDUET
- Serial number 97681662
- Filing date Nov 17, 2022
- Novavax, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97681649 - NUVIDENZA
- Serial number 97681649
- Filing date Nov 17, 2022
- Novavax, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97681657 - NUVODUA
- Serial number 97681657
- Filing date Nov 17, 2022
- Novavax, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97681647 - NUVIDENZA
- Serial number 97681647
- Filing date Nov 17, 2022
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97681655 - NUVODUA
- Serial number 97681655
- Filing date Nov 17, 2022
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97225039 - RESVAX
- Serial number 97225039
- Filing date Jan 18, 2022
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97180421 - WE FOCUS ON THIS SO THEY CAN FOCUS ON THAT
- Serial number 97180421
- Registration number 6833975
- Filing date Dec 20, 2021
- Novavax, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97168785 - CREATING TOMORROW'S VACCINES TODAY
- Serial number 97168785
- Filing date Dec 13, 2021
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97168786 - CREATING TOMORROW'S VACCINES TODAY
- Serial number 97168786
- Registration number 6982152
- Filing date Dec 13, 2021
- Novavax, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97168788
- Serial number 97168788
- Registration number 6982153
- Filing date Dec 13, 2021
- Novavax, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97168787
- Serial number 97168787
- Filing date Dec 13, 2021
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79337952 - MATRIX-C
- Serial number 79337952
- Registration number 7008612
- Filing date Nov 15, 2021
- Novavax AB
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79337951 - MATRIX-A
- Serial number 79337951
- Registration number 7008611
- Filing date Nov 15, 2021
- Novavax AB
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79337950 - MATRIX-M
- Serial number 79337950
- Registration number 6998552
- Filing date Nov 15, 2021
- Novavax AB
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97008364 - NOVAVAX
- Serial number 97008364
- Filing date Sep 2, 2021
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97008365 - NOVAVAX
- Serial number 97008365
- Registration number 6981969
- Filing date Sep 2, 2021
- Novavax, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90825809 - NANOFLU
- Serial number 90825809
- Filing date Jul 13, 2021
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90825812 - NANOFLU
- Serial number 90825812
- Filing date Jul 13, 2021
- Novavax, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90813420 - NUVAXOVID
- Serial number 90813420
- Filing date Jul 6, 2021
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90813423 - NUVAXOVID
- Serial number 90813423
- Filing date Jul 6, 2021
- Novavax, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90796624 - NUVIMAFLU
- Serial number 90796624
- Filing date Jun 25, 2021
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90792527 - NUENZAVAX
- Serial number 90792527
- Filing date Jun 24, 2021
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90793176 - NUFLENZYX
- Serial number 90793176
- Filing date Jun 24, 2021
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90792531 - NUVIMAFLU
- Serial number 90792531
- Filing date Jun 24, 2021
- Novavax, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90792533 - NUENZAVAX
- Serial number 90792533
- Filing date Jun 24, 2021
- Novavax, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90792535 - NUVYXAFLU
- Serial number 90792535
- Filing date Jun 24, 2021
- Novavax, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90792537 - NUVYXAFLU
- Serial number 90792537
- Filing date Jun 24, 2021
- Novavax, Inc.
- 42 - Scientific and technological services and research and design relating thereto

NIH Research Projectlast 12 months

processing...

Count: 8

Research Projects

Information Research Project
Development of a Virus-like Particle (VLP) Vaccine for RSV
- Application id 7744565
- Award notice date Sep 3, 2009
Information Research Project
Development of Recombinant SARS VLP Vaccines
- Application id 7184337
- Award notice date Apr 27, 2007
Information Research Project
Development of Recombinant SARS VLP Vaccines
- Application id 7014010
- Award notice date Feb 10, 2006
Information Research Project
Development of Recombinant SARS VLP Vaccines
- Application id 6835240
- Award notice date Feb 4, 2005
Information Research Project
Production of Non-Egg grown Influenza Vaccines
- Application id 6325245
- Award notice date Sep 27, 2000
Information Research Project
PRODUCTION OF NON-EGG GROWN INFLUENZA VACCINES
- Application id 6286116
- Award notice date May 3, 2000
Information Research Project
HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVDDT)-266030042
- Application id 6829015
Information Research Project
HIV Vaccine Design and Development Teams /HVDDT/-26630042
- Application id 6994668

Novavax, Inc.

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Methods and compositions for inducing immune responses against Clos...

Multivalent influenza nanoparticle vaccines

Corona virus vaccine formulations

Coronavirus vaccine formulations

Modified RSV F proteins and methods of their use

Vaccine compositions having improved stability and immunogenicity

Multivalent influenza nanoparticle vaccines

Vaccine compositions having improved stability and immunogenicity

Coronavirus vaccine formulations

Methods and compositions for inducing immune responses against Clos...

Modified RSV F proteins and methods of their use

Coronavirus vaccine formulations

Composition comprising iscom particles and live micro-organisms

Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV)...

Influenza vaccine

ISCOM preparation and use thereof

Functional influenza virus like particles (VLPs)

Functional influenza virus-like particles (VLPS)

Highly efficient influenza matrix (M1) proteins

Influenza vaccine

Vaccine compositions having improved stability and immunogenicity

Functional influenza virus like particles (VLPs)

Rabies glycoprotein virus-like particles (VLPS)

Modified RSV F proteins and methods of their use

Functional influenza virus-like particles (VLPs)

Highly efficient influenza matrix (M1) proteins

Functional influenza virus-like particles (VLPS)

Compositions comprising iscom particles and live micro-organisms

Modified RSV F proteins and methods of their use

Rabies glycoprotein virus-like particles (VLPS)

Patents Applicationslast 30 patents

CORONAVIRUS VACCINE FORMULATIONS

DOWNSTREAM PROCESS FOR PURIFICATION OF VIRAL PROTEINS WITH HYDROPHO...

QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF

CORONAVIRUS VACCINE FORMULATIONS

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

CORONAVIRUS VACCINE FORMULATIONS

VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY

CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM

CORONAVIRUS VACCINE FORMULATIONS

QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF

METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOS...

CORONAVIRUS VACCINE FORMULATIONS

MULTIVALENT INFLUENZA NANOPARTICLE VACCINES

CORONAVIRUS VACCINE FORMULATIONS

CORONAVIRUS VACCINE FORMULATIONS

METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE

QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF

COMPOSITION COMPRISING ISCOM PARTICLES AND LIVE MICRO-ORGANISMS

ISCOM PREPARATION AND USE THEREOF

VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY

METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOS...

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

INFLUENZA VACCINE

FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)

MULTIVALENT INFLUENZA NANOPARTICLE VACCINES

RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPS)

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

HIGHLY EFFICIENT INFLUENZA MATRIX (M1) PROTEINS

FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)

QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF

Trademarklast 30 trademarks

98117267 - CHOOSE TO PROTECT

97696833 - ORDINARY IS EXTRAORDINARY

97681661 - VAXDUET

97681662 - VAXDUET

97681649 - NUVIDENZA

97681657 - NUVODUA

97681647 - NUVIDENZA

97681655 - NUVODUA

97225039 - RESVAX

97180421 - WE FOCUS ON THIS SO THEY CAN FOCUS ON THAT